Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × copanlisib × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Breast Neoplasms 5 Lymphoma 4 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colonic Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Mycosis Fungoides 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 44 Rituximab 31 fludarabine 27 Magnetic Resonance Spectroscopy 13 Doxorubicin 13 Specimen Handling 12 Prednisone 12 Bendamustine Hydrochloride 12 fludarabine phosphate 11 Vincristine 11 Etoposide 11 pirtobrutinib 10 obinutuzumab 9 Lenalidomide 9 Biopsy 8 venetoclax 7 polatuzumab vedotin 7 glofitamab 7 Immunotherapy, Adoptive 7 zanubrutinib 6 pembrolizumab 6 etoposide phosphate 6 tafasitamab 5 ibrutinib 5 acalabrutinib 5 Leukapheresis 5 Dexamethasone 5 Carboplatin 5 tazemetostat 4 loncastuximab tesirine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡